Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF – Get Free Report) saw a significant increase in short interest in May. As of May 29th, there was short interest totaling 900 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
Jacobio Pharmaceuticals Group Stock Performance
Shares of JBPHF remained flat at $0.87 during mid-day trading on Monday. The stock’s fifty day simple moving average is $0.87 and its 200 day simple moving average is $0.86. Jacobio Pharmaceuticals Group has a twelve month low of $0.73 and a twelve month high of $1.10.
Jacobio Pharmaceuticals Group Company Profile
Jacobio Pharmaceuticals Group Co, Ltd. is a clinical‐stage biopharmaceutical company headquartered in Tianjin, China, specializing in the discovery and development of small‐molecule therapeutics for oncology. The company’s research platform is built around targeted kinase inhibitors and epigenetic modulators aimed at addressing acute leukemias and select solid tumors with high unmet medical need.
Jacobio’s pipeline comprises multiple preclinical and clinical‐stage programs focused on genetically defined cancers, including agents designed to inhibit mutant FLT3, menin‐MLL interactions and other oncogenic drivers.
Featured Articles
- Five stocks we like better than Jacobio Pharmaceuticals Group
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Jacobio Pharmaceuticals Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jacobio Pharmaceuticals Group and related companies with MarketBeat.com's FREE daily email newsletter.
